- Report
- March 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 150 Pages
Global
From €4597EUR$4,850USD£3,840GBP
- Report
- February 2025
- 150 Pages
Global
From €4597EUR$4,850USD£3,840GBP
- Report
- November 2024
- 150 Pages
Global
From €4597EUR$4,850USD£3,840GBP
- Report
- April 2025
- 89 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 89 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- August 2024
- 145 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- December 2024
- 186 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- November 2024
- 140 Pages
Global
From €4218EUR$4,450USD£3,524GBP
- Report
- July 2024
- 100 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- April 2024
- 140 Pages
Global
From €4691EUR$4,949USD£3,919GBP
- Report
- August 2024
- 180 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- July 2024
- 120 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- February 2025
- 188 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- May 2024
- 186 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- December 2024
- 200 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- April 2025
Global
From €4218EUR$4,450USD£3,524GBP
- Training
- March 2025
- 2 Days
Global
From €1513EUR$1,597USD£1,264GBP

The Drug Approval market is a key component of the Drug Discovery process. It involves the evaluation of a drug's safety and efficacy by regulatory authorities, such as the US Food and Drug Administration (FDA). This process is essential for the approval of a drug for commercial use. It involves the submission of a New Drug Application (NDA) to the FDA, which includes data from pre-clinical and clinical trials. The FDA then reviews the data and makes a decision on whether to approve the drug. The Drug Approval market is highly competitive, with many companies vying for approval of their drugs.
Companies in the Drug Approval market include pharmaceutical companies such as Pfizer, Merck, and GlaxoSmithKline, as well as biotechnology companies such as Amgen and Genentech. Other companies involved in the market include contract research organizations (CROs) and clinical research organizations (CROs). Show Less Read more